HPV Vaccination Rates Continue to Lag in U.S.
HPV vaccination rates are still too low to cut cervical cancer cases as much as is possible in the United States, a new report warns.
While HPV (human papillomavirus) vaccination has increased in recent years, rates remain well below the federal government's Healthy People 2020 goal of 80 percent of age-eligible adolescents, according to the recent report.
"We have a safe, effective vaccine that protects against a cancer-causing virus, and we applaud the efforts of cancer and immunization leaders joining forces and rising to the challenge of accelerating HPV vaccine uptake," said Barbara Rimer, chair of the President's Cancer Panel, which produced the report.
"Yet, the fact remains that this vaccine remains seriously underutilized -- we are still missing opportunities to prevent cancer and save lives," she added in a panel news release.
According to the U.S. Centers for Disease Control and Prevention, boys and girls aged 11 or 12 should get two shots of HPV vaccine six to 12 months apart. Those who receive their two shots less than five months apart require a third dose of HPV vaccine, the agency added.
Source: U.S. News & World Report